Maruyama T, Kasai H, Fukaya Y, Shiokawa M, Kimura T, Hamada Y
Front Microbiol. 2024; 15:1480874.
PMID: 39444685
PMC: 11496754.
DOI: 10.3389/fmicb.2024.1480874.
Henkel L, Jehn U, Tholking G, Reuter S
Front Transplant. 2024; 2:1160752.
PMID: 38993881
PMC: 11235362.
DOI: 10.3389/frtra.2023.1160752.
Komenkul V, Sukarnjanaset W, Komolmit P, Wattanavijitkul T
Eur J Clin Pharmacol. 2024; 80(8):1229-1240.
PMID: 38695888
DOI: 10.1007/s00228-024-03692-8.
Li Z, Wang X, Li D, Cheng S, Li Z, Guo H
BMC Nephrol. 2024; 25(1):48.
PMID: 38321419
PMC: 10848431.
DOI: 10.1186/s12882-024-03467-4.
Zheng P, Yu Z, Li L, Liu S, Lou Y, Hao X
Front Pharmacol. 2021; 12:727245.
PMID: 34630104
PMC: 8497784.
DOI: 10.3389/fphar.2021.727245.
Case Report: Low Hematocrit Leading to Tacrolimus Toxicity.
Piletta-Zanin A, De Mul A, Rock N, Lescuyer P, Samer C, Rodieux F
Front Pharmacol. 2021; 12:717148.
PMID: 34483924
PMC: 8415261.
DOI: 10.3389/fphar.2021.717148.
BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection.
Shen C, Wu B, Lien T, Yang A, Yang C
Viruses. 2021; 13(3).
PMID: 33809472
PMC: 7998398.
DOI: 10.3390/v13030487.
Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study.
Alghanem S, Soliman M, Alibrahim A, Gheith O, Kenawy A, Awad A
Front Pharmacol. 2021; 11:566638.
PMID: 33658922
PMC: 7919378.
DOI: 10.3389/fphar.2020.566638.
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry.
Al-Kofahi M, Oetting W, Schladt D, Remmel R, Guan W, Wu B
J Clin Pharmacol. 2021; 61(8):1035-1044.
PMID: 33512723
PMC: 11240873.
DOI: 10.1002/jcph.1823.
A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation.
Kim J, Wilson S, Undre N, Shi F, Kristy R, Schwartz J
Drugs R D. 2019; 19(2):201-212.
PMID: 31073875
PMC: 6544741.
DOI: 10.1007/s40268-019-0271-2.
A Theoretical Physiologically-Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition.
Emoto C, Johnson T, Hahn D, Christians U, Alloway R, Vinks A
CPT Pharmacometrics Syst Pharmacol. 2019; 8(5):273-284.
PMID: 30843669
PMC: 6539708.
DOI: 10.1002/psp4.12392.
The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients.
Schijvens A, van Hesteren F, Cornelissen E, Bootsma-Robroeks C, Bruggemann R, Burger D
Pediatr Nephrol. 2018; 34(3):507-515.
PMID: 30374607
PMC: 6349786.
DOI: 10.1007/s00467-018-4117-x.
Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients.
Uno T, Wada K, Matsuda S, Terada Y, Oita A, Kawase A
Eur J Drug Metab Pharmacokinet. 2018; 43(6):665-673.
PMID: 29691732
DOI: 10.1007/s13318-018-0478-6.
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.
Storset E, Hole K, Midtvedt K, Bergan S, Molden E, Asberg A
Br J Clin Pharmacol. 2017; 83(7):1457-1465.
PMID: 28146606
PMC: 5465334.
DOI: 10.1111/bcp.13248.
External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
Zhao C, Jiao Z, Mao J, Qiu X
Br J Clin Pharmacol. 2015; 81(5):891-907.
PMID: 26574188
PMC: 4834594.
DOI: 10.1111/bcp.12830.
The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients.
Zhu L, Wang H, Sun X, Rao W, Qu W, Zhang Y
J Pharm (Cairo). 2015; 2014:713650.
PMID: 26556199
PMC: 4590802.
DOI: 10.1155/2014/713650.
Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.
Ganetsky A, Miano T, Hughes M, Vonderheide R, Porter D, Reshef R
J Antimicrob Chemother. 2015; 70(7):2078-83.
PMID: 25881619
PMC: 4472330.
DOI: 10.1093/jac/dkv082.
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation.
Jacobo-Cabral C, Garcia-Roca P, Romero-Tejeda E, Reyes H, Medeiros M, Castaneda-Hernandez G
Br J Clin Pharmacol. 2015; 80(4):630-41.
PMID: 25846845
PMC: 4594699.
DOI: 10.1111/bcp.12649.
Interpreting tacrolimus concentrations during pregnancy and postpartum.
Hebert M, Zheng S, Hays K, Shen D, Davis C, Umans J
Transplantation. 2013; 95(7):908-15.
PMID: 23274970
PMC: 3637974.
DOI: 10.1097/TP.0b013e318278d367.
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
Bergmann T, Barraclough K, Lee K, Staatz C
Clin Pharmacokinet. 2012; 51(11):711-41.
PMID: 23018468
DOI: 10.1007/s40262-012-0007-8.
